SCHEMBL6080653

SCHEMBL6080653

CCOC(=O)C(C)(C)Oc1ccccc1OC.O=C1Cc2ccc(cc2)CO1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FBP1 P09467 6/20 0.45
PPARA Q07869 3/20 0.38
ABCB11 O95342 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
TSHR P16473 1/20 0.38
HTR2A P28223 1/20 0.38
PMP22 Q01453 1/20 0.38
PPARG P37231 3/20 0.38
NR5A1 Q13285 1/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
MAPT P10636 2/20 0.37
LMNA P02545 2/20 0.37
PLIN1 O60240 1/20 0.37
POLB P06746 1/20 0.37
PLIN5 Q00G26 1/20 0.37
ABHD5 Q8WTS1 1/20 0.37
PKM P14618 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12670823 0.82 FBP1 (0.56) FBP1PPARAABCB11CYP1A2CYP3A4
SCHEMBL4111678 0.70 FBP1 (0.58) FBP1PPARAABCB11CYP1A2CYP3A4
SCHEMBL7981278 0.69 FBP1 (0.60) FBP1PPARAABCB11CYP1A2CYP3A4
SCHEMBL6230252 0.68 FBP1 (0.67) FBP1PPARAABCB11CYP1A2CYP3A4
SCHEMBL4423002 0.68 PPARA (0.59) FBP1PPARAABCB11CYP1A2CYP3A4
SCHEMBL14092161 0.68 FBP1 (0.55) FBP1PPARAABCB11CYP1A2CYP3A4
SCHEMBL3485006 0.68 FBP1 (0.55) FBP1PPARAABCB11CYP1A2CYP3A4
SCHEMBL14047067 0.67 FBP1 (0.65) FBP1PPARAABCB11CYP1A2CYP3A4
SCHEMBL1549946 0.67 PPARA (0.48) FBP1PPARAABCB11CYP1A2CYP3A4
SCHEMBL15460021 0.67 PPARA (0.55) FBP1PPARAABCB11CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060079696-A1 Substituted compounds derived from N-(benzyl)phenylacetamide, preparation and uses GENFIT (FR) 2006-04-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060079696-A1 Substituted compounds derived from N-(benzyl)phenylacetamide, preparation and uses AADAC, NAT1, PARN FBP1 2946/4885PPARA 425/4885ABCB11 70/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.